AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Treating COPD with a combination inhaler can significantly reduce lung function decline, claim US researchers.
Previously, only smoking cessation has been shown to slow progression of the disease.
Findings from the 'Towards a revolution in COPD health' (TORCH) study suggest that treatment with a salmeterol/fluticasone propionate inhaler slows the rate of lung function decline compared with placebo.
TORCH has shown that combination treatment reduces the number of COPD flare-ups but has no effect on mortality rate.
The study included 6,112 patients, aged an average of 65, who had moderate to severe COPD. Participants were randomly assigned to …